Claire Leurent
Pfizer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Claire Leurent.
Alzheimers & Dementia | 2012
Timothy Nicholas; Sridhar Duvvuri; Claire Leurent; David Raunig; Tracey L. Rapp; Phillip Iredale; Carolyn Rowinski; Robert Carr; Patrick Roberts; Athan Spiros; Hugo Geerts
then challenged orally with CWD infected brains. Tonsil and rectal biopsies plus blood, saliva, feces and urine were collected every three months post-infection until the 9 month; and every 45 days thereafter. Results: Two vaccinated animals produced low antibody titers, two intermediate titers and one high titers of IgA and IgG anti-PrP. Both groups produced high titers of IgA and IgG against Salmonella. Six months post-infection 5 out of 6 controls and 3 out of 5 vaccinated showed histologically prion structures in the tonsils. Ayear post-infection one of the vaccinated animals remained prion free, with all controls being infected. The negative animal has the highest titers of IgA in saliva and IgG systemic against PrP. Immunoglobulins purified from saliva, feces and serum of this vaccinated deer reacts to PrP. Conclusions: Oral immunization can be used to overcome tolerance to self-PrP protein and produce a mucosal IgA and systemic IgG response to normal and conformational modified PrP in large mammals. High antibody titers might be enough to prevent transmission or to retard progression of PrP infection. This approach may lead to an effective anti-prion vaccine.
Alzheimers & Dementia | 2016
Claire Leurent; James Goodman; Eve H. Pickering; Ping He; Sridhar Duvvuri; Eddie Martucci; Scott Kellogg; Derek Purcell; Jerome Barakos; Gregory Klein; James W. Kupiec; Robert C. Alexander
Conclusions Though a gold standard of amyloid burden was not available, results indicate that a hybrid qualitative visual / quantitative method can be used to obtain greater concordance between quantitative and visual results. Clinical studies using only visual or only SUVR information for eligibility decisions must understand the implications of potential differences between the visual and quantitative methodologies.
Advances in Alzheimer's Disease | 2013
Timothy Nicholas; Sridhar Duvvuri; Claire Leurent; David Raunig; Tracey L. Rapp; Phil Iredale; Carolyn Rowinski; Robert Carr; Patrick Roberts; Athan Spiros; Hugo Geerts
Alzheimers & Dementia | 2012
Claire Leurent; Sridhar Duvvuri; David Raunig; Jeremias Antinew; Carolyn Rowinski; Laura Zumpano; Michelle Bergeron; Hetal S. Kocinsky; Joy Sieklucki; Timothy Nicolas; Tracey L. Rapp
Alzheimers & Dementia | 2011
Sarah Grimwood; Elena M. Drummond; Ken Zasadny; Marc B. Skaddan; Michael Aaron Brodney; Karen Coffman; Timothy Nicholas; Sridhar Duvvuri; David Raunig; Claire Leurent; Carolyn Rowinski; Yo-sub Park; Adam Ogden; Aarti Sawant; Emily Miller; Tracey L. Rapp; Yi Wang; Beata Planeta-Wilson; Jim Ropchan; Richard E. Carson; Evan D. Morris; Yu-Shin Ding; Elyse Katz
Alzheimers & Dementia | 2012
Sridhar Duvvuri; Timothy Nicholas; Claire Leurent; David Raunig; Anna Plotka; Elias Schwam; Sarah Grimwood; Carolyn Rowinski; Tracey L. Rapp
Alzheimers & Dementia | 2016
Ruolun Qiu; Richann Liu; Anne Marie Wills; Ping He; Claire Leurent; Eva Hajos-Korcsok; Laure Mendes da Costa; Robert C. Alexander
Alzheimers & Dementia | 2012
Claire Leurent; Joanne Bell; Sridhar Duvvuri; David Raunig; Hifan Huang; Anna Plotka; James P. Mancuso; Tracey L. Rapp; Grace M. Vandal; Clare B. Billing; James W. Kupiec
Alzheimers & Dementia | 2011
Rathna Iyer; Allen J. Duplantier; Michael Aaron Brodney; Bradley Snyder; Elizabeth C. Arnold; Laura McDowell; Claire Leurent; Faith Prior; Panayiotis Zagouras; Robin Roof
Alzheimers & Dementia | 2011
Timothy Nicholas; David Raunig; Sridhar Duvvuri; Anna Plotka; Elias Schwam; Sarah Grimwood; Yo-sub Park; Carolyn Rowinski; Tracey L. Rapp; Michelle Bergeron; Claire Leurent